TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26036329

Group type: EXPERIMENTAL
Intervention: Topical 30% resin lacquer once daily for 9 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Topical 5% amorolfine lacquer once weekly for 9 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Oral terbinafine 250 mg once daily for 3 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Oral terbinafine
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Topical 30% resin lacquer
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Topical 5% amorolfine lacquer
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness
Number of subjects: 73
Study: 23819909

Group type: EXPERIMENTAL
Intervention: Cool water immersion (20-24 °C)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Warm water immersion (37 °C)
Number of subjects: 201
Study: 21840914

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Brief advice (control)
Number of subjects: 92
Study: 20084896

Group type: EXPERIMENTAL
Intervention: rBS/WC oral cholera vaccine
Number of subjects: 3041

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3041
Study: 16680923

Group type: EXPERIMENTAL
Intervention: Mometasone furoate DPI, 200 microg, once daily in the evening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15166553

Group type: EXPERIMENTAL
Intervention: Propofol alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Remifentanil alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propofol with modest remifentanil concentrations
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of propofol and remifentanil
Number of subjects: 20
Study: 11822519

Group type: EXPERIMENTAL
Intervention: Research-based teaching programme
Number of subjects: 16

Group type: COMPARATOR
Intervention: Baseline knowledge and practice
Number of subjects: 16
Study: 9726718

Group type: EXPERIMENTAL
Intervention: Aerosolized terbutaline, 400 microg q6h
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8028519

Group type: EXPERIMENTAL
Intervention: Exercise training (primarily running)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Caloric restriction (dieting)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sedentary, nondieting controls
Number of subjects: 130
Study: 2663386

Group type: EXPERIMENTAL
Intervention: External shock-wave lithotripsy (ESL) and adjuvant ursodiol therapy
Number of subjects: 223

Group type: COMPARATOR
Intervention: Ursodiol therapy alone
Number of subjects: 223
Study: 4574639

Group type: EXPERIMENTAL
Intervention: 2 weeks cyclophosphamide therapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 8 weeks cyclophosphamide therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: steroid treatment alone
Number of subjects: 32
Study: 29600726

Group type: EXPERIMENTAL
Intervention: Aerobic Training + Resistance Training (AT+RT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Aerobic Training (AT)
Number of subjects: 73
Study: 27966565

Group type: EXPERIMENTAL
Intervention: Inulin (24g)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Resistant Starch (28g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (75g glucose)
Number of subjects: 25
Study: 25370206

Group type: EXPERIMENTAL
Intervention: 20-mg tadalafil
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: 100-mg sildenafil
Number of subjects: 383
Study: 23847252

Group type: EXPERIMENTAL
Intervention: Model-based iterative reconstruction (MBIR)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Adaptive statistical iterative reconstruction (ASIR)
Number of subjects: 51
Study: 21640360

Group type: EXPERIMENTAL
Intervention: Essential PUFA from flaxseed oil
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Long-chain PUFA from fish oil
Number of subjects: 51

Group type: COMPARATOR
Intervention: Soybean oil (Control)
Number of subjects: 51
Study: 18963025

Group type: EXPERIMENTAL
Intervention: IFN‐beta treated patients in remission
Number of subjects: 117

Group type: COMPARATOR
Intervention: Untreated patients with MS relapse
Number of subjects: 117
Study: 16880095

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate stress strain imaging
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no LAD lesions)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Coronary flow velocity reserve measurement
Number of subjects: 34
Study: 12964783

Group type: EXPERIMENTAL
Intervention: Dietary intervention for 6 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 10567758

Group type: EXPERIMENTAL
Intervention: Two-step gait initiation protocol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Two-step gait termination protocol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Midgait protocol
Number of subjects: 25
Study: 8696724

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (3000 cGy in 2 weeks)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy and surgery
Number of subjects: 74
Study: 2249406

Group type: EXPERIMENTAL
Intervention: 1 mgF- tablets plus fortnightly rinsing at school with 1000 ppmF-
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 1 mgF- tablets plus placebo rinsing
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo tablets plus 1000 ppmF- rinsing
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Active tablet/active rinse group
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Active tablet/placebo rinse group
Number of subjects: 192

Group type: COMPARATOR
Intervention: Tablet-only children
Number of subjects: 192
Study: 6996417

Group type: EXPERIMENTAL
Intervention: Ultrasonic measurement of fetal chest area between 32 and 36 weeks of gestation (Group A)
Number of subjects: 745

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Ultrasonic measurement of fetal chest area (Group A)
Number of subjects: 745
Study: 30730346

Group type: EXPERIMENTAL
Intervention: Intradermal Botulinum Toxin (BTX) injections
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 24
Study: 28126300

Group type: COMPARATOR
Intervention: Short-Term Androgen Deprivation (STAD)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Long-Term Androgen Deprivation (LTAD)
Number of subjects: 133
Study: 25510839

Group type: EXPERIMENTAL
Intervention: β-Alanine (BA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 18
Study: 24481564

Group type: EXPERIMENTAL
Intervention: Video message about amniocentesis and chorionic villus sampling
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Audio message about amniocentesis and chorionic villus sampling
Number of subjects: 176

Group type: COMPARATOR
Intervention: Text message about amniocentesis and chorionic villus sampling
Number of subjects: 176
Study: 23095307

Group type: EXPERIMENTAL
Intervention: adalimumab 40 mg/2 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study: 21172842

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU) 20 mg/kg/day
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 17652181

Group type: EXPERIMENTAL
Intervention: Cinacalcet 50 mg orally once daily for 8 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16324031

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2 microg.kg(‐1).h(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 50
Study: 11896478

Group type: EXPERIMENTAL
Intervention: Doxazosin (4 mg daily) and sildenafil (100 mg 1 h before sexual intercourse)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sildenafil and placebo
Number of subjects: 28
Study: 10213258

Group type: EXPERIMENTAL
Intervention: Surfactant treatment (S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 40
Study: 8750026

Group type: EXPERIMENTAL
Intervention: Right hand aiming at perturbed target (target jumped 3 cm to the right or left)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Left hand aiming at perturbed target (target jumped 3 cm to the right or left)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control condition (stationary target)
Number of subjects: 10
Study: 3042876

Group type: EXPERIMENTAL
Intervention: BS-WC vaccine
Number of subjects: 24770

Group type: COMPARATOR
Intervention: WC vaccine
Number of subjects: 24770
Study: 31166697

Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 1262

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 1262

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 1262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1262
Study: 28100551

Group type: EXPERIMENTAL
Intervention: Nintedanib (intervention in a 12-month, randomized, placebo-controlled trial)
Number of subjects: 428
Study: 26619338

Group type: EXPERIMENTAL
Intervention: Community based peer counselling (in addition to standard health facility breastfeeding promotion services)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard health facility breastfeeding promotion services (HFP) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community based peer counselling
Number of subjects: 0
Study: 24377642

Group type: EXPERIMENTAL
Intervention: 5 lessons smoking prevention program
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard anti-smoking education
Number of subjects: 55
Study: 21168840

Group type: EXPERIMENTAL
Intervention: Visual aid depicting clean and dirty colons in addition to standard written instructions
Number of subjects: 969

Group type: COMPARATOR
Intervention: Control group (standard written instructions only)
Number of subjects: 969

Group type: EXPERIMENTAL
Intervention: Visual aid group
Number of subjects: 969
Study: 19064822

Group type: EXPERIMENTAL
Intervention: Half-dose TIV
Number of subjects: 1114

Group type: COMPARATOR
Intervention: Full-dose TIV
Number of subjects: 1114
Study: 19499272

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (screening and patient education) by community pharmacists
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 262
Study: 16100237

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg kg(‐1) in isotonic saline 0.2 ml kg(‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine 0.1 mg kg(‐1) in isotonic saline 0.2 ml kg(‐1)
Number of subjects: 80
Study: 11966493

Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg
Number of subjects: 20
Study: 9710008

Group type: EXPERIMENTAL
Intervention: Diuretic (trichlormethiazide, 2 mg daily)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: NSAID-slow release (tenoxicam-SR, 20 mg daily)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Steroid (prednisolone, 20 mg daily for 2 weeks, then 10 mg daily for 2 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 7799337

Group type: EXPERIMENTAL
Intervention: Chrysotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gold alone
Number of subjects: 0
Study: 2841905

Group type: EXPERIMENTAL
Intervention: Carboplatin 300 mg/m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carboplatin 400 mg/m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carboplatin 450 mg/m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carboplatin (all doses)
Number of subjects: 30
Study: 1244812

Group type: EXPERIMENTAL
Intervention: Calcium heparinate (low doses, administered subcutaneously)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sodium pentosan polysulfate (administered intramuscularly)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 100
Study: 30851623

Group type: EXPERIMENTAL
Intervention: Exercise Program (EP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 30396605

Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (advising only)
Number of subjects: 44
Study: 26518596

Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Daytime Wakefulness
Number of subjects: 60
Study: 25146365

Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/losartan 5/100 mg/d (AML/LOS)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Losartan/hydrochlorothiazide 100/12.5 mg/d (LOS/HCTZ)
Number of subjects: 199
Study: 21592715

Group type: EXPERIMENTAL
Intervention: Ongoing group based diabetes self-management education (DSME)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 146
Study: 21180793

Group type: EXPERIMENTAL
Intervention: Fluoride-containing toothpastes
Number of subjects: 206
Study: 20664127

Group type: EXPERIMENTAL
Intervention: Humor group (self-selected humor for 30 minutes daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (standard cardiac therapy)
Number of subjects: 48
Study: 15458908

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d or 120 mg/d
Number of subjects: 7705
Study: 11167350

Group type: EXPERIMENTAL
Intervention: Cetirizine (C) 10 mg daily for 2 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P) for 2 weeks
Number of subjects: 12
Study: 9930389

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 7270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7270
Study: 8034508

Group type: EXPERIMENTAL
Intervention: HA vaccine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hepatitis B vaccine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Immunoglobulin alone
Number of subjects: 28
Study: 3141640

Group type: EXPERIMENTAL
Intervention: Lipid infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Glucose infusion
Number of subjects: 6
Study: 31974576

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 376
Study: 30573030

Group type: EXPERIMENTAL
Intervention: Patients with PAD and diabetes
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Patients without diabetes
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Every 1% increase in HbA1c
Number of subjects: 13885
Study: 27106880

Group type: EXPERIMENTAL
Intervention: 12-month physical activity intervention
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 211
Study: 26253219

Group type: EXPERIMENTAL
Intervention: Psychoeducation (2-hour sessions once a week for 6 weeks)
Number of subjects: 430
Study: 24283773

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 7.5 mg per week for 12 weeks
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 58
Study: 21348912

Group type: EXPERIMENTAL
Intervention: Combined therapy with dutasteride (0.5 mg) and tamsulosin (0.4 mg)
Number of subjects: 4844
Study: 19056900

Group type: EXPERIMENTAL
Intervention: 20,000 IU cholecalciferol twice a week
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: 20,000 IU once a week plus placebo
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo twice a week
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Both groups receiving cholecalciferol
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 445
Study: 16563974

Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac)
Number of subjects: 67

Group type: COMPARATOR
Intervention: microemulsion cyclosporine (mCyA)
Number of subjects: 67
Study: 12910217

Group type: EXPERIMENTAL
Intervention: Laparoscopic prosthetic hernia repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open prosthetic hernia repair
Number of subjects: 0
Study: 10228257

Group type: EXPERIMENTAL
Intervention: Somatostatin infusion
Number of subjects: 220

Group type: COMPARATOR
Intervention: Normal saline infusion (placebo)
Number of subjects: 220
Study: 8934457

Group type: EXPERIMENTAL
Intervention: Memory for conversation
Number of subjects: 0
Study: 1655299

Group type: EXPERIMENTAL
Intervention: edrophonium 1 mg.kg‐1 (single-dose)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: edrophonium 0.75 mg.kg‐1 (single-dose)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: edrophonium 0.25 mg.kg‐1 followed by 0.75 mg.kg‐1 (divided-dose)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: edrophonium 0.25 mg.kg‐1 followed by 0.50 mg.kg‐1 (divided-dose)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: edrophonium (divided doses)
Number of subjects: 48
Study: 6751003

Group type: EXPERIMENTAL
Intervention: Diuretic treatment (25 mg hydrochlorothiazide and 50 mg triamterene)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 331
Study: 31690945

Group type: EXPERIMENTAL
Intervention: Focused ultrasound thalamotomy (FUS-T) in the postpivotal group
Number of subjects: 179

Group type: COMPARATOR
Intervention: Focused ultrasound thalamotomy (FUS-T)
Number of subjects: 179
Study: 30711665

Group type: EXPERIMENTAL
Intervention: Broad training using a web-based brain game suite, Brain HQ
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Broad training using a strategy video game, Rise of Nations
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Directed training for Instrumental Activities of Daily Living (IADL) using web-based programs for driving and fraud avoidance
Number of subjects: 230

Group type: COMPARATOR
Intervention: Active control condition of puzzle solving
Number of subjects: 230
Study: 27911341

Group type: EXPERIMENTAL
Intervention: MAO-B inhibitors
Number of subjects: 1616
Study: 27460618

Group type: EXPERIMENTAL
Intervention: Cognitive Training & Exercise (CT&E)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cognitive Training (CT)
Number of subjects: 16
Study: 23730719

Group type: EXPERIMENTAL
Intervention: Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Number of subjects: 341

Group type: COMPARATOR
Intervention: Nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Number of subjects: 341

Group type: COMPARATOR
Intervention: Standard Care Only
Number of subjects: 341
Study: 21941012

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g of NaHCO3 per kilogram body mass)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.15 g of corn flour per kilogram body mass)
Number of subjects: 0
Study: 19685757

Group type: EXPERIMENTAL
Intervention: Shenmai injection 0.6 mL x kg(‐1) added to physiological saline 250 mL after anaesthesia before CPB
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physiological saline 250 mL
Number of subjects: 30
Study: 17854336

Group type: EXPERIMENTAL
Intervention: Parental provision of alcohol and home alcohol availability
Number of subjects: 1388

Group type: EXPERIMENTAL
Intervention: Student report of receiving alcohol from their parent or taking it from home during their last drinking occasion
Number of subjects: 1388
Study: 15109974

Group type: EXPERIMENTAL
Intervention: Systemic lidocaine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Phasic mechanical stimulation
Number of subjects: 10
Study: 12090798

Group type: EXPERIMENTAL
Intervention: Sterillium
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Manorapid
Number of subjects: 17

Group type: COMPARATOR
Intervention: Desderman, AHD 2000, Mucasept A, Spitacid
Number of subjects: 17
Study: 10555740

Group type: EXPERIMENTAL
Intervention: Proclear Compatibles lenses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acuvue lenses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Soflens 66 lenses
Number of subjects: 10
Study: 8526620

Group type: EXPERIMENTAL
Intervention: Duraflo II heparin coat
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carmeda Biological Active Surface
Number of subjects: 40

Group type: COMPARATOR
Intervention: Uncoated equipment (Control)
Number of subjects: 40
Study: 2405964

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 6154110

Group type: EXPERIMENTAL
Intervention: Interferon administration
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 41
Study: 29656495

Group type: EXPERIMENTAL
Intervention: Resorbable membrane (RES)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Titanium-reinforced nonresorbable membrane (N-RES)
Number of subjects: 23
Study: 27362458

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied after eccentric exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive recovery (PR) after eccentric exercise
Number of subjects: 10
Study: 24394548

Group type: EXPERIMENTAL
Intervention: FAN intervention
Number of subjects: 0
Study: 22992861

Group type: EXPERIMENTAL
Intervention: Group A performed one meniscal repair each month
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Group B performed one meniscal repair at three months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Group C performed no repairs during this interim phase
Number of subjects: 19
Study: 20535962

Group type: EXPERIMENTAL
Intervention: Peptide vaccine with high-dose IL-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dendritic cell (DC) vaccine of prostate-acid protein plus GM-CSF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MAGE-A3 vaccine for non-small cell lung cancer
Number of subjects: 0
Study: 18179915

Group type: EXPERIMENTAL
Intervention: Skeletonized internal thoracic artery harvesting (Group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pedicled internal thoracic artery harvesting (Group 2)
Number of subjects: 24